DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Barber LD, Pflugfelder SC, Tauber J. et al.
Phase III safety evaluation of cyclosporine 0.1 % ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
Ophthalmology 2005;
112: 1790-1794
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.